Save the Cord Foundation recently interviewed Dr. Michael Chez (Sutter Health / Sutter Neurological Institute) about the encouraging results coming out of his autism clinical trials using cord blood. In addition, Dr. Chez spoke about the exciting work in this area also being done at Duke University by Dr. Joanne Kurtzberg and Geraldine Dawson, PhD.
Autism is a complicated developmental disability that affects as many as 1 in 68 children in the United States alone, according to the Centers for Disease Control and Prevention (source: CDC.gov). Imagine how many lives could be changed, if we could find a cure or treatment for autism. Many researchers feel that using a child’s own autologous cord blood could be the key to unlocking this mystery via the emerging field of regenerative medicine.
In this interview, Dr. Chez details the background and results of his clinical trials studying cord blood’s effect on autism. This particular study is significant because it included a placebo which is not always the case in cord blood research. Specifically, this was a double-blind placebo crossover study meaning that ultimately all participants received their cord blood.
Watch the video now and learn about the latest research using cord blood to potentially treat autism:
Save the Cord Foundation wishes to thank Dr. Michael Chez
for sharing his valuable insight on autism clinical trials using cord blood.
Test your knowledge on cord blood!
- Do you know the basic facts on cord blood?
- Did you know cord blood is often used to treat blood cancers?
- Have you heard the latest in cord blood research?